YK-1169健康人体耐受性、药动学及药物相互作用研究
[Translation] Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Humans
拟在健康受试者中开展随机、单盲、剂量递增、安慰剂对照的耐受、药动学及药物相互作用研究,评价YK-1169在健康受试者中单次、多次给药的安全性及耐受性、单次及多次给药在健康受试者体内的药动学特征、及头孢吡肟与阿维巴坦之间的药物相互作用。
[Translation] A randomized, single-blind, dose-escalating, placebo-controlled study of tolerance, pharmacokinetics and drug interactions in healthy subjects is planned to evaluate the efficacy of single and multiple doses of YK-1169 in healthy subjects. Safety and tolerability, single- and multiple-dose pharmacokinetics in healthy subjects, and drug interactions between cefepime and avibactam.
100 Clinical Results associated with Nanjing Libowei Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Nanjing Libowei Pharmaceutical Co., Ltd.
100 Deals associated with Nanjing Libowei Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Nanjing Libowei Pharmaceutical Co., Ltd.